Dariya Andreevna Tyapkina

Dariya Andreevna Tyapkina

Auto-generated profile, based on publicly available information

Dariya Andreevna Tyapkina

Saratov State Medical University named after V. I. Razumovsky

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2024 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
ATA. R. Tyapaeva
A. R. Tyapaeva
ENE. A. Naumova
E. A. Naumova
OSO. N. Semenova
O. N. Semenova
YBYu. V. Bulaeva
Yu. V. Bulaeva
DTD. A. Tyapkina
D. A. Tyapkina
ABA. A. Boroday
A. A. Boroday
Aim. To evaluate the relationship of various factors with adherence to therapy in cardiovascular patients after a coronavirus disease 2019 (COVID-19).Material and methods. The study included 284 patients (inpatients — 176, outpatients — 108) with cardiovascular diseases (hypertension, heart failure (HF), coronary artery disease, atrial fibrillation) after COVID-19. We collected data on cardiovascular history, made a questionnaire survey about COVID-19 course (symptoms, their severity, self-assessment of the disease severity). Paraclinical diagnostic investigations were carried out. In addition, 1, 3, 6 months after recovery, all respondents were invited for examination, laboratory tests, and survey using the Hospital Anxiety and Depression Scale (HADS). Cardiovascular therapy adherence was assessed at 1, 3 and 6 months after recovery and adherence to COVID-19 treatment 1 month after inclusion in the study by comparing the compliance of the drugs prescribed at discharge with its actual use.Results. In total, 212 respondents continued study participation after 1 month, while 64,2% were adherent to cardiovascular therapy and 56,6% — to COVID-19 therapy. Compliance at 3 and 6 months was 60,4% (n=212) and 52,8% (n=188), respectively. A moderate correlation was found between adherence to treatment and the persistence of apprehension 1 month after recovery (r=0,33, p<0,05), moderate or severe weakness during disease (r=0,31, p<0,05), COVID-19 severity (r=0,39, p25% (n=64, 36,4%) were more adherent to standard cardiovascular therapy, prescribed in accordance with clinical guidelines (r=0,336, p<0,05). Adverse events in the form of a hypertensive crisis, arrhythmias, decompensated HF 1, 3, 6 months after recovery significantly increased the compliance with medical recommendations (p<0,05). Medication adherence regarding COVID-19 was associated with the disease severity, HF history, apprehension and anxiety, weakness, and decreased exercise tolerance (p0,05). Compliance after 1, 3, 6 months was positively influenced by COVID-19 severity, the subjective feeling of weakness, apprehension and anxiety during disease and the persistence of a subjective feeling of anxiety after recovery. Adverse events (hypertensive crisis, arrhythmia, decompensated HF) during 1, 3 and 6 months after COVID-19 significantly (p<0,05) increased adherence to treatment.

15 April 2023 in The Clinician
Verified
Journal Article
Open access
PDF file
EGE. V. Grigoryeva
E. V. Grigoryeva
DTD. A. Tyapkina
D. A. Tyapkina
ABA. A. Boroday
A. A. Boroday
IBI. S. Blokhin
I. S. Blokhin
IKI. E. Kondrashkin
I. E. Kondrashkin
ARA. P. Rebrov
A. P. Rebrov
Aim. To study the features of the course of COVID-19 in pregnant women, the outcomes of a new coronavirus infection and pregnancy, the effect of concomitant pathology on the severity of the course and the frequency of complications of COVID-19.Materials and methods. In the course of the work, a retrospective analysis of 109 medical histories of pregnant women who were treated in the infectious diseases department in 2021 with a diagnosis of COVID-19 was carried out. Anamnesis, concomitant pathology, results of objective examination, laboratory and instrumental methods of research, therapy, complications, outcomes of COVID-19 and pregnancy were evaluated.Results. The majority of pregnant women had moderate – 55 % and severe – 24 % COVID-19, 7 % – extremely severe and only 14 % – mild. A third of pregnant women had concomitant pathology, arterial hypertension was the most common; 80 % of pregnant women had complications of COVID-19: cytokine storm – in 50 % of patients, acute respiratory distress syndrome – in 17 %, of which 5 % required artificial lung ventilation. The mortality rate was 4.6 %. The structure of pregnancy complications was dominated by gestational hypertension, gestational diabetes, premature placental abruption, preeclampsia. Complications of childbirth – premature birth and premature discharge of amniotic fluid. However, in most cases, pregnancy (75 %) and childbirth (71 %) proceeded without complications. Women in 95 % of cases were discharged from the hospital with recovery or significant clinical improvement.Conclusion. Despite the prevalence of moderate and severe forms of COVID-19 in pregnant women, a high percentage of concomitant pathology and complications, in most cases favorable outcomes of both COVID-19 and pregnancy were noted. The presence of hypertension syndrome should probably be considered as a prognostically unfavorable marker of severe course and adverse outcomes of COVID-19 in pregnant women.

27 October 2021 in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
Verified
Journal Article
Closed access
SDSamoilova Daria Dmitrievna
Samoilova Daria Dmitrievna
BABoroday Alexandra Aleksandrovna
Boroday Alexandra Aleksandrovna
TATyapkina Daria Andreevna
Tyapkina Daria Andreevna
To assess the impact of the novel coronavirus infection on the mental health of the population, a search was performed in the PubMed electronic database, as well as in scientific electronic libraries, such as eLIBRARY.RU and «CyberLeninka». The mental manifestations of anxiety disorders include: irritability, impatience, a feeling of tension, inability to relax, inability to concentrate, memory impairment, fatigue, fears, obsessive thoughts, insecurity and anxiety. The increased level of anxiety may be the result of misinformation transmitted through social networks. People who follow the news about COVID-19 the most experience more anxiety. Health workers are at the greatest risk of negative psychological impact during pandemics, especially if they have direct contact with the infected. The most pronounced symptoms were observed in middle and junior medical staff, women and young people working in the «red zone». During the pandemic, the levels of anxiety, depression and stress are significantly higher in the age group of 21–40 years. Women are at a higher risk of depression. During the COVID-19 pandemic, people with higher levels of education had higher levels of anxiety, depression and stress. People who have had a history of health problems, as well as those who suffer from poor health, may feel more vulnerable to the new disease. Most adolescents reacted to the stressful situation with suicidal forms of behavior — auto-aggressive and autistic-depressive. Thus, the COVID-19 pandemic can affect the mental health of individuals, various communities and social groups. Therefore, in the current crisis, it is vital to identify people who are prone to psychological disorders in order to preserve and improve the mental health of the population as a whole with the help of appropriate psychological strategies, methods and interventions.

21 November 2022 in Medical alphabet
Verified
Journal Article
Open access
PDF file
IAI. A. Arzhaeva
I. A. Arzhaeva
ISI. A. Salov
I. A. Salov
DTD. A. Tyapkina
D. A. Tyapkina
ABA. A. Boroday
A. A. Boroday
Современное состояние проблемы хронических воспалительных заболеваний придатков матки: диагностика и лечение

31 March 2022 in Nauka Molodykh (Eruditio Juvenium)
Verified
Journal Article
Closed access
ABAleksandra A. Boroday
Aleksandra A. Boroday
RURazumovsky Saratov State Medical University
Razumovsky Saratov State Medical University
DTDar’ya A. Tyapkina
Dar’ya A. Tyapkina
ATAl’fiya R. Tyapayeva
Al’fiya R. Tyapayeva
OSOl’ga N. Semenova
Ol’ga N. Semenova
ENElizaveta A. Naumova
Elizaveta A. Naumova
BACKGROUND: SARS-CoV-2 virus, which induces COVID-19, not only affects the lungs, but also negatively affects the cardiovascular system, causing decompensation of the existing cardiovascular diseases (CVD). AIM: Тo find out the peculiarities of the course and treatment of the new coronavirus infection COVID-19 in patients with cardiovascular diseases (CVD). MATERIALS AND METHODS: A survey was conducted among patients with CVD undergoing outpatient treatment for COVID-19. A special questionnaire was developed containing 48 questions about the symptoms of COVID-19 and the prescribed therapy. The respondents were ill with a new coronavirus infection between August 2020 and January 2021. The survey involved 54 patients aged 43–82 years, among them 36 (66.7%) women and 18 (33.3%) men. Patients of age groups 61–70 years and 51–60 years prevailed (33.3% and 29.6%, respectively). The respondents had the following CVD: arterial hypertension — 54 (100%) and coronary heart disease (exertion angina) — 16 (29.6%). RESULTS. COVID-19 was manifested by cough — in 32 (59.3%) patients, shortness of breath — in 34 (63%). There was marked weakness (44 (81.5%)), limitation of physical activity (48 (88.9%)). Of the skin manifestations, patients described itching (14 (25.9%)). Myalgia was present in 40 (74.1%) patients and joint pain — in 36 (66.7%). Of the classic manifestations of COVID-19 infection, 34 (40.7%) and 22 (50%) patients had reduction or loss of olfaction and gustatory sensations. On the part of the gastrointestinal tract, the following symptoms were present: lack of appetite (6 (11.1%)), nausea (6 (11.1%)) and diarrhea (2 (3.7%)). Neurological manifestations of COVID-19, such as episodes of dizziness, disorientation in space and time, and feelings of fear and anxiety, were observed in 38 (70.6%) respondents. There were also unusual manifestations of the disease: increased blood pressure, decreased blood pressure, weakness in the legs, disorders in urination, ring-shaped granuloma, conjunctivitis, tickling in throat. Treatment: most patients with mild and moderate course of the disease took drugs that are not specified in the recommendations of the Ministry of Health of the Russian Federation for COVID-19. CONCLUSIONS: The majority of patients with CVD had manifestations of COVID-19 on the part of the respiratory, musculoskeletal systems, as well as neurological manifestations of the disease. Skin manifestations and manifestations on the part of the gastrointestinal tract were present only in a small part of the respondents.

6 December 2023 in Лечащий врач
Verified
Journal Article
Closed access
ISI.A. Salov
I.A. Salov
IAI.A. Arzhaeva
I.A. Arzhaeva
DTD.A. Tyapkina
D.A. Tyapkina
Background. In vitro fertilization is a way to treat infertility, but it has a fairly common and dangerous complication – ovarian hyperstimulation syndrome, which can affect the development of pregnancy and its outcome. Objective. The purpose was to analyze the impact of ovarian hyperstimulation syndrome on the course of pregnancy. The study included 123 women who were hospitalized at the Yu. Ya. Gordeev State Clinical Hospital No. 1 in 2021-2022. The patients were divided into three groups: the main (n = 43) – women with ovarian hyperstimulation syndrome and after in vitro fertilization; comparison group (n = 40) – women without ovarian hyperstimulation syndrome and after in vitro fertilization; and the control group (n = 40) – women who got pregnant naturally. The patient was interviewed, the impact of pregnancy on the occurrence and development of ovarian hyperstimulation syndrome, the impact of ovarian hyperstimulation syndrome on the course of pregnancy, and the presence of possible complications during pregnancy were assessed. Results. In the main group, the number of patients with inflammatory diseases of the reproductive system, polycystic ovaries, with tubal-peritoneal and endocrine factors of infertility, primary infertility, with repeated in vitro fertilization and repeated pregnancy is greater than in the comparison group. The main group is dominated by working patients with higher education. Pregnant patients are more likely to have moderate to mild ovarian hyperstimulation syndrome than non-pregnant women. Multiple pregnancy contributes to the occurrence of ovarian hyperstimulation syndrome. Ovarian hyperstimulation syndrome contributes to the development of threatened miscarriage, spontaneous abortion, false contractions up to 37 weeks of gestation, premature rupture of membranes, preeclampsia, placental insufficiency, and fetal growth retardation syndrome. Ovarian hyperstimulation syndrome increases the likelihood of early reproductive losses, preterm birth, low birth weight babies, and the likelihood of a caesarean section. Ovarian hyperstimulation syndrome more often develops in women with endocrine or tubal-peritoneal factors of infertility, with primary infertility, repeated pregnancy and repeated in vitro fertilization; in working patients with higher education. Pregnancy reduces the likelihood of developing severe and moderate ovarian hyperstimulation syndrome. Multiple pregnancy contributes to the formation of ovarian hyperstimulation syndrome. Ovarian hyperstimulation syndrome contributes to various complications of pregnancy and increases the likelihood of early reproductive losses, increases the likelihood of preterm birth and low birth weight, and creates an indication for caesarean section.